Spots Global Cancer Trial Database for dalteparin
Every month we try and update this database with for dalteparin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | NCT05171075 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Dalteparin | 18 Years - | Anthos Therapeutics, Inc. | |
| Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery | NCT01061411 | Clear Cell Sarc... Recurrent Renal... Stage III Renal... Stage IV Renal ... | Dalteparin Pharmacological... Sunitinib Malat... | 18 Years - | Roswell Park Cancer Institute | |
| WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism | NCT03297359 | Cancer Venous Thromboe... Obesity | Dalteparin | 18 Years - | Ottawa Hospital Research Institute | |
| Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients | NCT00966277 | Pancreatic Canc... Venous Thromboe... | Dalteparin | 18 Years - | M.D. Anderson Cancer Center | |
| Dalteparin in Preventing Blood Clots in Patients With Lung Cancer | NCT00519805 | Lung Cancer Thromboembolism | dalteparin quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
| Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) | NCT00239980 | Ovarian Cancer | dalteparin | 18 Years - 75 Years | Ontario Clinical Oncology Group (OCOG) | |
| Standard Therapy With or Without Dalteparin in Treating Patients With Advanced Breast, Lung, Colorectal, or Prostate Cancer | NCT00003674 | Breast Cancer Colorectal Canc... Lung Cancer Prostate Cancer Veno-occlusive ... | dalteparin standard therap... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme | NCT00028678 | Brain and Centr... | dalteparin radiation thera... | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients | NCT00135876 | Venous Thromboe... Brain Tumors | dalteparin | 18 Years - | Ontario Clinical Oncology Group (OCOG) | |
| Dalteparin in Preventing DVT in Participants With Cancer | NCT00525057 | Bone Sarcoma Femur Fracture Lymphoma Metastatic Neop... Pathologic Frac... Plasma Cell Mye... Soft Tissue Sar... | Dalteparin | 30 Years - | M.D. Anderson Cancer Center | |
| Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients | NCT00952380 | Venous Thromboe... | dalteparin | - 18 Years | Pfizer | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients | NCT00952380 | Venous Thromboe... | dalteparin | - 18 Years | Pfizer | |
| Cancer Venous Thromboembolism (VTE) | NCT02073682 | Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Cancer | Edoxaban Dalteparin Low molecular w... | 18 Years - | Daiichi Sankyo | |
| Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) | NCT00239980 | Ovarian Cancer | dalteparin | 18 Years - 75 Years | Ontario Clinical Oncology Group (OCOG) | |
| Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery | NCT01444612 | Thrombosis, Ven... | dalteparin enoxaparin fondaparinux unfractionated ... | 18 Years - | GlaxoSmithKline | |
| Dalteparin in Preventing DVT in Participants With Cancer | NCT00525057 | Bone Sarcoma Femur Fracture Lymphoma Metastatic Neop... Pathologic Frac... Plasma Cell Mye... Soft Tissue Sar... | Dalteparin | 30 Years - | M.D. Anderson Cancer Center | |
| Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma | NCT01518465 | Stage I Multipl... Stage II Multip... Stage III Multi... | dalteparin lenalidomide dexamethasone laboratory biom... | 18 Years - | University of Southern California | |
| Apixaban for the Treatment of Venous Thromboembolism in Patients With Cancer | NCT03045406 | Venous Thromboe... | Apixaban Dalteparin | 18 Years - | Fadoi Foundation, Italy | |
| Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer | NCT00031837 | Pancreatic Canc... Thromboembolism | dalteparin gemcitabine hyd... quality-of-life... | 18 Years - 120 Years | University of Rochester | |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | NCT02585713 | Cerebral Vein T... Deep Vein Throm... Gonadal Thrombo... Hepatic Thrombo... Malignant Neopl... Mesenteric Thro... Metastatic Mali... Portal Vein Thr... Pulmonary Embol... Renal Vein Thro... Splenic Thrombo... Venous Thromboe... | Apixaban Dalteparin Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
| STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis | NCT05255003 | Cancer-associat... Thrombocytopeni... | Enoxaparin Dalteparin Tinzaparin | 18 Years - | Ottawa Hospital Research Institute | |
| Direct Oral Anticoagulants (DOACs) Versus LMWH +/- Warfarin for VTE in Cancer | NCT02744092 | Cancer Venous Thromboe... Deep Vein Throm... Pulmonary Embol... Blood Clot | Rivaroxaban Apixaban Edoxaban Dabigatran Warfarin Dalteparin Enoxaparin Fondaparinux | 18 Years - | Alliance Foundation Trials, LLC. | |
| WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism | NCT03297359 | Cancer Venous Thromboe... Obesity | Dalteparin | 18 Years - | Ottawa Hospital Research Institute | |
| The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis | NCT00216866 | Embolism and Th... | Dalteparin Warfarin | 18 Years - | Lawson Health Research Institute | |
| The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis | NCT00216866 | Embolism and Th... | Dalteparin Warfarin | 18 Years - | Lawson Health Research Institute | |
| A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE | NCT05171075 | Venous Thromboe... Deep Venous Thr... Pulmonary Embol... | Abelacimab Dalteparin | 18 Years - | Anthos Therapeutics, Inc. | |
| Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism | NCT02585713 | Cerebral Vein T... Deep Vein Throm... Gonadal Thrombo... Hepatic Thrombo... Malignant Neopl... Mesenteric Thro... Metastatic Mali... Portal Vein Thr... Pulmonary Embol... Renal Vein Thro... Splenic Thrombo... Venous Thromboe... | Apixaban Dalteparin Questionnaire A... | 18 Years - | Academic and Community Cancer Research United | |
| STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis | NCT05255003 | Cancer-associat... Thrombocytopeni... | Enoxaparin Dalteparin Tinzaparin | 18 Years - | Ottawa Hospital Research Institute | |
| Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | NCT00462852 | Pancreatic Canc... Thromboembolism | dalteparin gemcitabine hyd... diagnostic labo... | 18 Years - | National Cancer Institute (NCI) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
